D-66458-1 Class II Terminated
FDA drug recall D-66458-1 was initiated by Sandoz, Inc on Oct 9, 2013 and is designated Class II. Reason for recall: Cross contamination with other products: Sandoz is recalling certain lots of Ropinirole Extended Release Tablets 2 mg due to the potential presence of carryover coming from the previously manufactured… The recall status is terminated (terminated Jul 7, 2014). Affected quantity: 692 bottles (90 count).
Recall details
- Product Type
- Drugs
- Report Date
- Nov 13, 2013
- Initiation Date
- Oct 9, 2013
- Termination Date
- Jul 7, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 692 bottles (90 count)
Product description
Ropinirole, extended-release tablets, 2 mg, 90 count bottle, Rx only, Manufactured in India by Sandoz Private Ltd, for Sandoz Inc, Princeton, NJ 08540, NDC 0781-5780-92
Reason for recall
Cross contamination with other products: Sandoz is recalling certain lots of Ropinirole Extended Release Tablets 2 mg due to the potential presence of carryover coming from the previously manufactured product, mycophenolate mofetil.
Distribution pattern
Nationwide
Code information
Lot DJ2744, Exp 12/2014
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-66458-1
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026